FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

STE

SterisNYSE · Health Care Equipment · Health Care
Previous close
227.12
Change
−5.02 / −2.16%
FinDog View
Bullish
52-Week Range ?
195.14 – 269.44
P/E (TTM) ?
27.6
Forward P/E ?
17.9
Based on consensus earnings for the next 12 months
Market Cap
$22.2B
1M
+8.15%
S&P 500 −0.91% over same period
Volume / Avg Volume
993K / 731K
1.36× average
Latest earnings analysisFY2027 Q1Reported 2026-08-05

Steris FY2027 Q1: revenue up 7.3%, adjusted EPS $2.59, guidance held

Steris delivered a clean fiscal 2027 first quarter: revenue of $1.49 billion, gross margin up to 45.8%, and adjusted EPS of $2.59 that beat the $2.5272 consensus. Management kept its full-year earnings range but trimmed free cash flow to about $800 million because capital spending is rising. Read the quarter as steady demand, better margins and reaffirmed guidance — with the cash-flow haircut as the one thing to watch.

Read the full analysis →
Revenue$1.49BYoY +7.30%
EPS (non-GAAP)$2.59Beatest. $2.53
Next-day move−0.40%

Price History

Closing price · USD1M6M1Y5Y
180200220240260280EFY27 Q1 EarningsEFY26 Q4 EarningsEFY26 Q3 EarningsEFY26 Q2 Earnings2025-102026-012026-052026-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 30.01M6M1Y5Y
25303540452025-102026-012026-052026-082026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-03
in 2 days · time TBD
Consensus EPS
$2.70
Last quarter EPS $2.59
Avg. next-day move over the last 6 reports
±5.8%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 9 of its 5-year rangeCheap
5-year range 26.7 – 181.9 · Median 39.1
Last 4 quarters: $340M in buybacks + $247M in dividends, 2.65% of market cap combined
P/E (TTM)
27.6
P/B
3.1
P/S
3.7
Dividend Yield
1.02%
Earnings Reaction
Over the last 6 reports, the stock moved ±5.8% on average on the first trading day after, rising 4 times
Most recent −0.40%
Volatility & Correlation
1-year beta 0.41 · Correlation with S&P 500 0.20Low beta
Annualized volatility 26% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 1 · $0.96MNet selling $0.96M
  • 08-12Sohi MohsenDirectorSell$0.96M4,058 shares · Avg price 235.78
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2027 Q11.49+7.3%45.8%0.290.200.28—
FY2026 Q41.59+7.3%43.9%0.320.220.252.24
FY2026 Q31.50+9.2%43.8%0.270.190.201.96
FY2026 Q21.46+9.9%44.2%0.270.190.201.94
FY2026 Q11.39+8.7%45.1%0.250.180.331.79
FY2025 Q41.48+4.3%43.3%0.220.150.191.48
FY2025 Q31.37+5.6%44.5%0.250.170.241.75
FY2025 Q21.33+7.3%43.6%0.220.150.151.51
FY2025 Q11.28+8.1%44.7%0.190.150.201.46
FY2024 Q41.42+10.8%41.1%—-0.000.16-0.01
FY2024 Q31.30+16.7%43.2%0.230.140.171.42
FY2024 Q21.24+13.5%44.1%0.190.120.061.16

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView